Fast Market Research

New Market Study Published: Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2013

Fast Market Research recommends "Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2013" from Global Markets Direct, now available


Boston, MA -- (SBWIRE) -- 02/04/2014 -- Global Market Direct's pharmaceuticals report, "Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2013" provides data on the Intra-Cellular Therapies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Intra-Cellular Therapies, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Intra-Cellular Therapies, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Intra-Cellular Therapies, Inc. - Brief Intra-Cellular Therapies, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Intra-Cellular Therapies, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Intra-Cellular Therapies, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Intra-Cellular Therapies, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Intra-Cellular Therapies, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Intra-Cellular Therapies, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Intra-Cellular Therapies, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Intra-Cellular Therapies, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Intra-Cellular Therapies, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Intra-Cellular Therapies, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Immunovative Therapies, Ltd. - Product Pipeline Review - 2013
- Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2013
- Degenerative Disc Disease - Pipeline Review, H2 2013
- Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2013
- H. Lundbeck A/S - Product Pipeline Review - 2013
- Insomnia - Pipeline Review, H2 2013
- Alzheimer's Disease - Pipeline Review, H2 2013
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Shire Plc - Product Pipeline Review - 2013
- Novo Nordisk A/S - Product Pipeline Review - 2013